Rudi's View: Link Admin, Clinuvel Pharma & Altium
Rudi's View: Link Admin, Clinuvel Pharma & Altium May 17, 2019 In this week's Weekly Insights (this is Part Two): -All About Dividends -Royal Commission: Ongoing Impact -Quote Of The Week -No Weekly Insights Next Week -FNArena's Corporate Reporting Monitor -June Rebalance For ASX200 Index -Conviction Calls (with update) -Rudi On Tour -AIA Conference Special [Non-highlighted parts appeared in Part One on Thursday] By Rudi Filapek-Vandyck, Editor FNArena Royal Commission: Ongoing Impact A recent encounter with an industry veteran has taught me the domestic industry of funds managers and financial planners is most likely facing even more upheaval and transformation than I had assumed previously - see also Weekly Insights last week, "Value & The Eye Of The Beholder". On one hand we have the cohort of aging pensioners and retirees who, faced with Labor's new franking ideas and low returns in general, will be eying further reduction in costs, where possible. This points to direct shares ownership or ETFs, but certainly away from actively managed funds whose costs are higher and not necessarily offering a better return (certainly not for income oriented investors). On the other hand, there already is pressure on financial planners to lower the costs of managing the income generating capital. Since financial planners like to retain their own margin, here too a trend is being established towards ETFs, away from actively managed funds. Thirdly, industry super funds are also taking another look at their costs and allocation of funds with outside managers. Their problem is the size of the Australian share market, which remains rather small, in particular at the top.
[Show full text]